![Valerie Jolliffe](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Valerie Jolliffe
Amministratore Delegato presso Javelin Ventures Ltd.
Profilo
Valerie Celia Jolliffe is currently the Chief Executive Officer at Javelin Ventures Ltd.
and a Principal at Chrysalis VCT Management Ltd.
She is also a Trustee at Practical Action, Beat, Alcohol Research UK, and Imperial Health Charity.
In the past, she worked as a Director at Odontis Ltd., a Non-Executive Director at OSspray Ltd., and a Secretary at Vaxome Ltd.
Posizioni attive di Valerie Jolliffe
Società | Posizione | Inizio |
---|---|---|
Javelin Ventures Ltd.
![]() Javelin Ventures Ltd. Investment ManagersFinance Javelin Ventures Ltd (Javelin Ventures) is a venture capital firm founded in 2001 by Valerie Jolliffe and Janis Anderson. The firm is headquartered in London, United Kingdom. | Amministratore Delegato | 01/01/2001 |
Beat
![]() Beat Investment Trusts/Mutual FundsMiscellaneous Beat provides healthcare services. The company was founded in 1989 and is headquartered in Norwich, the United Kingdom. | Direttore/Membro del Consiglio | 01/01/2012 |
Chrysalis VCT Management Ltd.
![]() Chrysalis VCT Management Ltd. Investment ManagersFinance Chrysalis VCT Management Ltd. (Chrysalis) is an independent UK venture capital firm which was established in 1998 to manage the Chrysalis VCT PLC a Venture Capital Trust. The firm is headquartered in London. | Investitore di Private Equity | - |
Practical Action
![]() Practical Action Investment Trusts/Mutual FundsMiscellaneous Practical Action is a development charity that utilizes technology to combat poverty in developing countries. The non-profit company is based in Rugby, UK and has subsidiaries in the United Kingdom. The British company was founded in 1966 by Fritz Schumacher, and Paul Smith Lomas has been the CEO of the company since 2010. | Direttore/Membro del Consiglio | - |
Alcohol Research UK
![]() Alcohol Research UK Miscellaneous Commercial ServicesCommercial Services Alcohol Research UK is an alcohol charity that aims to reduce the harm caused by alcohol. The non-profit company is based in London, UK. The British company fund, commission, and conducts high-quality research to enrich the knowledge base and improve the lives of those affected by alcohol harm. The company was founded in 2017. The CEO is Richard Piper. | Direttore/Membro del Consiglio | - |
Imperial Health Charity
![]() Imperial Health Charity Miscellaneous Commercial ServicesCommercial Services Imperial Health Charity is an organization that provides funding to community organizations working to improve the health and wellbeing of people most affected by Covid-19. The non-profit company is based in London, UK. The British company has committed £360,000 to this cause. The charity also partners with museums to help patients experience culture in the capital. Ian Lush has been the CEO of the company since 2014. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Valerie Jolliffe
Società | Posizione | Fine |
---|---|---|
Odontis Ltd.
![]() Odontis Ltd. Miscellaneous Commercial ServicesCommercial Services Odontis is developing a biological replacement tooth product - the BioToothTM. The research is lead by Professor Paul Sharpe at King's College London Dental Institute. His team has demonstrated that tooth development can be initiated in stem cells, and that fully formed teeth can be created in developmental models. This is pioneering in that it represents one of the very few examples of a fully integrated tissue engineered organ. The technology opens the potential for the implantation of cultured cells in patients to grow and replace damaged or missing teeth. Odontis has attracted over £2 million of funding to date to progress the technology to commercial development. | Direttore/Membro del Consiglio | 18/01/2011 |
Vaxome Ltd.
![]() Vaxome Ltd. Pharmaceuticals: MajorHealth Technology Vaxome Ltd. developed vaccine delivery technology. The firm offered a novel vaccine delivery technology for antigen presentation and delivery system for stimulating T cell-mediated immune responses. The company was founded by Ping Wang in 2004 and was headquartered in London, the United Kingdom. | Segretario Aziendale | - |
OSspray Ltd.
![]() OSspray Ltd. Chemicals: Major DiversifiedProcess Industries OSspray Ltd. provides bioactive powders for teeth cutting, cleaning and whitening. It engages in the innovation of biomaterials for minimally invasive dentistry of therapeutic air polishing solutions that restore and maintain tooth structure and overall oral health. The company was founded in 2004 by Paul Robinson, Larry Hench and Ian Dennis Thompson and is headquartered in London, GB. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 9 |
---|---|
Javelin Ventures Ltd.
![]() Javelin Ventures Ltd. Investment ManagersFinance Javelin Ventures Ltd (Javelin Ventures) is a venture capital firm founded in 2001 by Valerie Jolliffe and Janis Anderson. The firm is headquartered in London, United Kingdom. | Finance |
OSspray Ltd.
![]() OSspray Ltd. Chemicals: Major DiversifiedProcess Industries OSspray Ltd. provides bioactive powders for teeth cutting, cleaning and whitening. It engages in the innovation of biomaterials for minimally invasive dentistry of therapeutic air polishing solutions that restore and maintain tooth structure and overall oral health. The company was founded in 2004 by Paul Robinson, Larry Hench and Ian Dennis Thompson and is headquartered in London, GB. | Process Industries |
Vaxome Ltd.
![]() Vaxome Ltd. Pharmaceuticals: MajorHealth Technology Vaxome Ltd. developed vaccine delivery technology. The firm offered a novel vaccine delivery technology for antigen presentation and delivery system for stimulating T cell-mediated immune responses. The company was founded by Ping Wang in 2004 and was headquartered in London, the United Kingdom. | Health Technology |
Odontis Ltd.
![]() Odontis Ltd. Miscellaneous Commercial ServicesCommercial Services Odontis is developing a biological replacement tooth product - the BioToothTM. The research is lead by Professor Paul Sharpe at King's College London Dental Institute. His team has demonstrated that tooth development can be initiated in stem cells, and that fully formed teeth can be created in developmental models. This is pioneering in that it represents one of the very few examples of a fully integrated tissue engineered organ. The technology opens the potential for the implantation of cultured cells in patients to grow and replace damaged or missing teeth. Odontis has attracted over £2 million of funding to date to progress the technology to commercial development. | Commercial Services |
Beat
![]() Beat Investment Trusts/Mutual FundsMiscellaneous Beat provides healthcare services. The company was founded in 1989 and is headquartered in Norwich, the United Kingdom. | Miscellaneous |
Chrysalis VCT Management Ltd.
![]() Chrysalis VCT Management Ltd. Investment ManagersFinance Chrysalis VCT Management Ltd. (Chrysalis) is an independent UK venture capital firm which was established in 1998 to manage the Chrysalis VCT PLC a Venture Capital Trust. The firm is headquartered in London. | Finance |
Practical Action
![]() Practical Action Investment Trusts/Mutual FundsMiscellaneous Practical Action is a development charity that utilizes technology to combat poverty in developing countries. The non-profit company is based in Rugby, UK and has subsidiaries in the United Kingdom. The British company was founded in 1966 by Fritz Schumacher, and Paul Smith Lomas has been the CEO of the company since 2010. | Miscellaneous |
Alcohol Research UK
![]() Alcohol Research UK Miscellaneous Commercial ServicesCommercial Services Alcohol Research UK is an alcohol charity that aims to reduce the harm caused by alcohol. The non-profit company is based in London, UK. The British company fund, commission, and conducts high-quality research to enrich the knowledge base and improve the lives of those affected by alcohol harm. The company was founded in 2017. The CEO is Richard Piper. | Commercial Services |
Imperial Health Charity
![]() Imperial Health Charity Miscellaneous Commercial ServicesCommercial Services Imperial Health Charity is an organization that provides funding to community organizations working to improve the health and wellbeing of people most affected by Covid-19. The non-profit company is based in London, UK. The British company has committed £360,000 to this cause. The charity also partners with museums to help patients experience culture in the capital. Ian Lush has been the CEO of the company since 2014. | Commercial Services |
- Borsa valori
- Insiders
- Valerie Jolliffe